3 recruiting. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 3 |
Follow Systemic Therapy: new trials by email Literature Review of Systemic Therapy trials Research Report on Systemic Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer Cytoreductive Gastrectomy - Metastatic Gastric Cancer, Gastric Cancer | Not applicable | Recruiting | University Medical Center Ho Chi Minh City (UMC) | 250 | 2025-08-01 | 2025-08-27 |
| The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma TACE, Ablation, Lenvatinb - Recurrent Hepatocellular Carcinoma, Lenvatinib | Not applicable | Recruiting | Sun Yat-sen University | 116 | 2024-10-01 | 2024-12-03 |
| TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT Transjugular intrahepatic portosystemic shunt, Lenvatinib, PD-1 inhibitor - Hepatocellular Carcinoma, Portal Vein Tumor Thrombus | Not applicable | Recruiting | Sun Yat-sen University | 42 | 2024-10-01 | 2025-01-13 |
Carcinoma, Hepatocellular (2) · Stomach Neoplasms (1)
Digestive System Diseases (3) · Digestive System Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Adenocarcinoma (2) · Carcinoma (2) · Liver Diseases (2) · Liver Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Stomach Diseases (1)
Immune Checkpoint Inhibitors (1) · Portasystemic Shunt, Transjugular Intrahepatic (1) · lenvatinib (1)
Sun Yat-sen University (2) · University Medical Center Ho Chi Minh City (UMC) (1)
China (2) · Vietnam (1)
Feng Duan (2)